Stockreport

Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer's Disease

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Study Continuation Follows Review of Site Level Data and Recommendation of Data Monitoring CommitteeBMS Remains Blinded to Study Data PRINCETON, N.J.--(BUSINESS WIRE) [Read more]